Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A1 | P43005 | 2/20 | 0.70 |
| ▸ | GSR | P00390 | 2/20 | 0.58 |
| ▸ | GRM8 | O00222 | 1/20 | 0.58 |
| ▸ | GRM6 | O15303 | 1/20 | 0.58 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.58 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.58 |
| ▸ | GRM5 | P41594 | 1/20 | 0.58 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.58 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.58 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.58 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.58 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.58 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.58 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.58 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.58 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.58 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.58 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1983229 | 1.00 | SLC1A1 (0.70) | SLC1A1GSRGRM8GRM6GRIN2D | |
| SCHEMBL1666146 | 1.00 | SLC1A1 (0.70) | SLC1A1GSRGRM8GRM6GRIN2D | |
| Hydrochloric Acid SCHEMBL19520881 | 0.98 | SLC1A1 (0.68) | SLC1A1GSRGRM8GRM6GRIN2D | |
| SCHEMBL28377520 | 0.98 | SLC1A1 (0.68) | SLC1A1GSRGRM8GRM6GRIN2D | |
| Ammonia Solution, Strong SCHEMBL27721206 | 0.98 | SLC1A1 (0.68) | SLC1A1GSRGRM8GRM6GRIN2D | |
| SCHEMBL28160356 | 0.98 | SLC1A1 (0.68) | SLC1A1GSRGRM8GRM6GRIN2D | |
| Hydrochloric Acid SCHEMBL10516366 | 0.98 | SLC1A1 (0.68) | SLC1A1GSRGRM8GRM6GRIN2D | |
| SCHEMBL16343347 | 0.91 | SLC1A1 (0.60) | SLC1A1GSRGRM8GRM6GRIN2D | |
| Leucine SCHEMBL8642033 | 0.89 | SLC1A1 (0.68) | SLC1A1GSRGRM8GRM6GRIN2D | |
| Adipic Acid SCHEMBL6739298 | 0.89 | SLC1A1 (0.58) | SLC1A1GSRGRM8GRM6GRIN2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1827 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746912-A1 | ORGANIC CYTOTOXIN OLIGOMERS AND USES THEREOF AS A PAYLOAD IN ANTIBODY-DRUG CONJUGATES | Simris Biologics GmbH (DE) | 2026-05-27 | — | — | EP | claimed |
| US-12590123-B2 | Compounds and methods for treating cancer, viral infections, and allergic conditions | WASHINGTON UNIVERSITY (US) | 2026-03-31 | — | — | US | claimed |
| US-20250361280-A1 | CONJUGATED HEPCIDIN MIMETICS | PROTAGONIST THERAPEUTICS INC (US) | 2025-11-27 | — | — | US | claimed |
| EP-4577248-A1 | A METHOD OF MODIFYING AN ORGANIC CYTOTOXIN FOR USE AS A PAYLOAD IN AN ANTIBODY-DRUG CONJUGATE AND MODIFIED ORGANIC CYTOTOXINS DERIVED THEREFROM | Simris Biologics GmbH (DE) | 2025-07-02 | — | — | EP | claimed |
| WO-2025111296-A1 | ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES USING THE SAME | II-VI DELAWARE, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-20250171495-A1 | MUTLI-TARGETED SERINE PROTEASE INHIBITORS FOR TREATMENT OF CANCER AND VIRAL INFECTION | WASHINGTON UNIVERSITY | 2025-05-29 | — | — | US | claimed |
| US-20250170216-A1 | CONJUGATED HEPCIDIN MIMETICS | PROTAGONIST THERAPEUTICS, INC. | 2025-05-29 | — | — | US | claimed |
| CN-119488454-A | Compound anti-aging skin-tightening polypeptide skin care product and preparation method thereof | 珞珈(深圳)生物科技有限公司 | 2025-02-21 | — | — | CN | claimed |
| CN-119470406-A | Phthalic dicarboxaldehyde disinfectant concentration detection test paper and preparation method thereof | 山东新华莎罗雅生物技术有限公司 | 2025-02-18 | — | — | CN | claimed |
| WO-2025021727-A1 | ORGANIC CYTOTOXIN OLIGOMERS AND USES THEREOF AS A PAYLOAD IN ANTIBODY-DRUG CONJUGATES | SIMRIS BIOLOGICS GMBH (DE) | 2025-01-30 | — | — | WO | claimed |
| US-5007930-A | Coating a supplementation or replacement; dentistry, bone prosthetics | THE DOW CHEMICAL COMPANY (US) | 1991-04-16 | — | — | US | claimed |
| EP-0362031-A1 | Compounds active against malaria of the tissues, and process for their preparation | LA REGION WALLONNE (BE) | 1990-04-04 | — | — | EP | claimed |
| US-4842604-A | MOLDING AND IMPLANTING POROUS MATERIAL; POLYESTER OR AMINO ACID POLYMER | THE DOW CHEMICAL COMPANY (US) | 1989-06-27 | — | — | US | claimed |
| US-4698375-A | POLYGLYCOLIC ACID, LATIC ACID, HYDROXYBUTYRATE, ALPHA-AMINO ACID | THE DOW CHEMICAL COMPANY (US) | 1987-10-06 | — | — | US | claimed |
| US-4652585-A | ANTISEPTICS, CLEANING COMPOUNDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1987-03-24 | — | — | US | claimed |
| US-4636526-A | Composites of unsintered calcium phosphates and synthetic biodegradable polymers useful as hard tissue prosthetics | THE DOW CHEMICAL COMPANY (US) | 1987-01-13 | — | — | US | claimed |
| US-4525495-A | CONTAINING AMINO ACID POLYMER | THE DOW CHEMICAL COMPANY (US) | 1985-06-25 | — | — | US | claimed |
| US-4493828-A | Use of thyrotropin releasing hormone and related peptides as poultry growth promotants | MERCK & CO., INC. (US) | 1985-01-15 | — | — | US | claimed |
| US-4041232-A | Amphotericin B methyl ester salts | E. R. SQUIBB & SONS, INC. (US) | 1977-08-09 | — | — | US | claimed |
| US-3936469-A | Process for preparing N-carboxylic anhydrides of amino acids | KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JA) | 1976-02-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250361280-A1 | CONJUGATED HEPCIDIN MIMETICS | HAMP, VIP, HDGF | SLC1A1 2582/4885GSR 2619/4885GRM8 3906/4885 |
| US-12590123-B2 | Compounds and methods for treating cancer, viral infections, and allergic conditions | TMPRSS2, TMPRSS4, F2RL3 | SLC1A1 3295/4885GSR 2569/4885GRM8 3280/4885 |
| US-20250171495-A1 | MUTLI-TARGETED SERINE PROTEASE INHIBITORS FOR TREATMENT OF CANCER AND VIRAL INFECTION | TMPRSS2, PRSS1, PRSS2 | SLC1A1 3965/4885GSR 2610/4885GRM8 3159/4885 |
| US-20250170216-A1 | CONJUGATED HEPCIDIN MIMETICS | HAMP, VIP, HDGF | SLC1A1 2655/4885GSR 2329/4885GRM8 3533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.